UNITED STATES CAPECITABINE MARKET BY MANUFACTURERS, STATES, TYPE AND APPLICATION, FORECAST TO 2022

Oct 2017 121

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.

Scope of the Report:
This report focuses on the Capecitabine in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers
- Roche
- Teva
- Mylan
- Hikma
- Hengrui Medicine
- Cipla
- Reliance Group
- Hetero

Market Segment by States, covering
- California
- Texas
- New York
- Florida
- Illinois

Market Segment by Type, covers
- 500 mg
- 150 mg

Market Segment by Applications, can be divided into
- Breast Cancer
- Colorectal Cancer
- Stomach Cancer

There are 17 Chapters to deeply display the United States Capecitabine market.

Chapter 1, to describe Capecitabine Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Capecitabine, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Capecitabine, for each state, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;

Chapter 12, Capecitabine market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe sales channel, distributors, traders, dealers etc.

Chapter 16 and 17, to describe Capecitabine Research Findings and Conclusion, Appendix, methodology and data source.

Table of Contents

Related reports :

(Oct 17)

Preclinical Tomography System is used tomography technology to the visualization of living animals for research purposes. Sco...

(Oct 17)

Environmental monitoring during pharmaceutical and biopharmaceutical production is crucial for ensuring the safety of formulated drug produc...

(Oct 17)

Hyperhidrosis is a condition characterized by abnormally increased sweating, in excess of that required for regulation of body temperature. ...

(Oct 17)

Elastic therapeutic tape is an elastic cotton strip with an acrylic adhesive that is used with the intent of treating pain and disability fr...

(Oct 17)

Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is s...

(Oct 17)

Cholesterol is a kind of sterol or steroid, of which the chemical formula is C27H46O. Cholesterol is a kind of flaky crystal under solid sta...

UNITED STATES CAPECITABINE MARKET BY MANUFACTURERS, STATES, TYPE AND APPLICATION, FORECAST TO 2022


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*